You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

binimetinib

Showing 26 - 50 of 51
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neurofibromatosis Type 1, Plexiform Neurofibroma Trial in United States (Binimetinib)

Active, not recruiting
  • Neurofibromatosis Type 1
  • Plexiform Neurofibroma
  • Binimetinib
  • Birmingham, Alabama
  • +21 more
Dec 4, 2021

BRAF V600E-mutant Metastatic Colorectal Cancer Trial in Worldwide (encorafenib, Binimetinib, Cetuximab)

Active, not recruiting
Has Results
  • BRAF V600E-mutant Metastatic Colorectal Cancer
  • New York, New York
  • +44 more
Aug 8, 2022

Melanoma, Metastasis Trial in Melbourne (Binimetinib, Encorafenib, Palbociclib)

Recruiting
  • Melanoma
  • Metastasis
  • Binimetinib
  • +2 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Jan 19, 2021

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +5 more
  • Boston, Massachusetts
  • +4 more
May 25, 2022

Targeted Therapies in BRAF Positive Metastatic Melanoma in US

Active, not recruiting
  • Melanoma
  • New York, New York
    Pfizer Investigational Site
Feb 18, 2022

Solid Tumor, Colorectal Cancer Trial in Oxford (PF-02341066, PD-0325901, Binimetinib)

Completed
Has Results
  • Solid Tumor
  • Colorectal Cancer
  • Oxford, United Kingdom
    Oxford University Hospital NHS Trust
Jun 14, 2021

Malignant Melanoma Trial in Germany (Encorafenib, Binimetinib, Pembrolizumab)

Completed
  • Malignant Melanoma
  • Freiburg, Baden-Württemberg, Germany
  • +10 more
Feb 13, 2021

Solid Tumor Trial in United States (PF-07284892, lorlatinib, binimetinib)

Recruiting
  • Solid Tumor
  • Orange, California
  • +6 more
Feb 15, 2022

Solid Tumor, Adult Trial in United States (JAB-3312, Binimetinib, Pembrolizumab)

Recruiting
  • Solid Tumor
  • NSCLC
  • Phoenix, Arizona
  • +14 more
Oct 26, 2022

Lung Cancer, Anaplastic Lymphoma Kinase Gene Translocation, ROS1 Rearrangement Trial in Boston (Lorlatinib, Crizotinib,

Recruiting
  • Lung Cancer
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 7, 2021

Melanoma, Colorectal Cancer, Non-Small-Cell Lung Cancer Trial in Springdale, Nashville (PF-07799933, binimetinib, cetuximab)

Recruiting
  • Melanoma
  • +4 more
  • Fayetteville, Arkansas
  • +23 more
Jan 19, 2023

MSS, RAS-mutant Colorectal Cancer Trial in Worldwide (binimetinib, nivolumab, ipilimumab)

Completed
Has Results
  • MSS
  • RAS-mutant Colorectal Cancer
  • binimetinib
  • +2 more
  • Los Angeles, California
  • +49 more
Dec 8, 2021

Binimetinib Plus Encorafenib Real Life Investigation of Next

Recruiting
  • Melanoma Stage IV
  • Melanoma Stage III
  • Graz, Austria
  • +58 more
Jan 15, 2021

Metastatic Uveal Melanoma, Cutaneous Melanoma, Colorectal Cancer Trial in Australia, Canada, United States (IDE196, Binimetinib,

Recruiting
  • Metastatic Uveal Melanoma
  • +3 more
  • Scottsdale, Arizona
  • +13 more
May 10, 2022

Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Los Angeles (Binimetinib, Docetaxel, Laboratory Biomarker

Withdrawn
  • Recurrent Non-Small Cell Lung Carcinoma
  • Stage IV Non-Small Cell Lung Cancer
  • Binimetinib
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 22, 2020

Melanoma Trial in Worldwide (Encorafenib, Binimetinib, Pembrolizumab)

Recruiting
  • Melanoma
  • Tucson, Arizona
  • +112 more
Jul 26, 2022

Malignant Melanoma, NSCLC, Brain Tumors, Primary Trial in United States (PF-07284890, Binimetinib, Midazolam)

Recruiting
  • Malignant Melanoma
  • +4 more
  • Duarte, California
  • +71 more
Dec 29, 2022

Lungcancer Trial in Canada (Binimetinib, Pemetrexed, Carboplatin)

Completed
  • Lungcancer
  • Binimetinib
  • +2 more
  • Edmonton, Alberta, Canada
  • +3 more
Apr 1, 2021

Recurrent Melanoma, Stage IV Melanoma Trial in Los Angeles (Raf kinase inhibitor LGX818, binimetinib, laboratory biomarker

Withdrawn
  • Recurrent Melanoma
  • Stage IV Melanoma
  • Raf kinase inhibitor LGX818
  • +2 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Jul 23, 2020

Melanoma of Unknown Primary, Metastatic Malignant Tumor in Lymph Node, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 Trial in

Not yet recruiting
  • Melanoma of Unknown Primary
  • +5 more
  • Binimetinib
  • +5 more
  • (no location specified)
Feb 13, 2020

Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Locally Advanced Malignant Solid Neoplasm
  • Binimetinib
  • +22 more
  • (no location specified)
Dec 2, 2022

Biliary Tract Tumors Trial in Belgium, France, United Kingdom (Futibatinib, Ivosidenib, Zanidatamab)

Not yet recruiting
  • Biliary Tract Neoplasms
  • Brussels, Belgium
  • +56 more
Nov 7, 2022

BRAF V600E-mutant Metastatic Colorectal Cancer Trial in Worldwide (Encorafenib, Binimetinib, Cetuximab)

Active, not recruiting
Has Results
  • BRAF V600E-mutant Metastatic Colorectal Cancer
  • Phoenix, Arizona
  • +428 more
Mar 7, 2022

Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma Trial in United States

Recruiting
  • Acral Lentiginous Melanoma
  • +6 more
  • Binimetinib
  • +3 more
  • Birmingham, Alabama
  • +309 more
Nov 8, 2021

NSCLC Trial in Worldwide (Sasanlimab Prefilled syringe, Encorafenib, Binimetinib)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Sasanlimab Prefilled syringe
  • +5 more
  • Duarte, California
  • +96 more
Jan 18, 2023